Docetaxel Injection, Solution
Product Images NDC 67457-533

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Docetaxel (NDC 67457-533). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structure (Image 1)

Structure (Image 1)
FDA Label Image

Figure-9 (Image 10)

Figure-9 (Image 10)
FDA Label Image

Figure 10 (Image 11)

Figure 10 (Image 11)
This appears to be a graph or chart showing Survival Probability and Survival Time for a group of patients. It appears that there are varying percentages for survival based on elapsed time. However, without additional context or further information, it is difficult to provide a more specific description.*
FDA Label Image

Carton (Image 12)

Carton (Image 12)
This is a description of Docetaxel Injection, USP, a ready-to-add, single-vial formulation that contains 10mg docetaxel anhydrous USP, 260mg polysorbate 80, 4mg anhydrous citric acid, and 23% v/v alcohol USP in polyethylene glycol 300. The usual dosage varies, and users must refer to the package insert for instructions on dosage, handling and use. The solution should be retained in the original packaging and protected from light, and the storage temperature should be between 20-25℃ (68-77°F). The Docetaxel Injection, USP vials can be used for up to 28 days when stored between 2-8℃ (36-46°F) and protected from light. The warning note indicates that the product must be kept out of children's reach. The package insert also contains complete instructions and users should check concentration before preparation. This is a Mylan product and is a Cytotoxic Agent.*
FDA Label Image

Figure 1 (Image 2)

Figure 1 (Image 2)
FDA Label Image

Figure 2 (Image 3)

Figure 2 (Image 3)
FDA Label Image

Figure-3 (Image 4)

Figure-3 (Image 4)
This appears to be a survival analysis chart showing cumulative probability of survival over time (in months). The log-rank p value is reported as 0.010 which suggests a statistically significant difference in survival between groups being compared. However, without additional context, it is not possible to determine the specifics of the comparison being made.*
FDA Label Image

Figure-4 (Image 5)

Figure-4 (Image 5)
This is a graph illustrating the cumulative probability of survival over time for a given population. The X-axis shows the survival time in months while the Y-axis indicates the cumulative probability of survival. The log-rank p-value, which is a statistical measure of the difference between two survival curves, is reported to be 0.13.*
FDA Label Image

Figure 5 (Image 6)

Figure 5 (Image 6)
This text seems to be a chart showing survival probability over time in months. The chart displays the survival probability percentages on the y-axis and the length of months on the x-axis. It appears to have been cut off, as there are only two numbers visible for the "Survival Time" section at the bottom. The chart likely pertains to some form of medical research or study.*
FDA Label Image

Figure-6 (Image 7)

Figure-6 (Image 7)
FDA Label Image

Figure-7 (Image 8)

Figure-7 (Image 8)
FDA Label Image

Figure-8 (Image 9)

Figure-8 (Image 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.